Duration of tachypnea, defined as hours with respiratory rate greater than 60 breaths per minute · patients with the management of transient tachypnea of the newborn
2 findings from 1 review
Length of hospital stay · patients with the management of transient tachypnea of the newborn
1 finding from 1 review
Pneumothorax · patients with the management of transient tachypnea of the newborn
It is very uncertain whether CPAP changes pneumothorax ‒NIPPV versus CPAP compared with nasal ventilation (NIPPV or NHFV) (very low certainty).
2 findings from 1 review
Mortality before hospital discharge · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes mortality before hospital discharge compared with invasive respiratory therapy (very low certainty).
1 finding from 1 review
Death or chronic lung disease · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in death or chronic lung disease compared with nCPAP used (low certainty).
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in intraventricular haemorrhage, Papile grade 3/4 compared with nCPAP used (low certainty).
1 finding from 1 review
Neurodevelopmental disability · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
1 finding from 1 review
Mortality before hospital discharge · preterm infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in mortality before hospital discharge compared with nIPPV used (low certainty).
1 finding from 1 review
Endotracheal intubation To discharge · preterm infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in endotracheal intubation To discharge compared with nIPPV used (low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
nHFV may leads to lower chronic lung disease compared with nIPPV used (low certainty).
1 finding from 1 review
Death or chronic lung disease · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Neurodevelopmental disability · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Mortality before hospital discharge · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Endotracheal intubation or reintubation To discharge · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Endotracheal intubation or reintubation To discharge · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes endotracheal intubation or reintubation To discharge compared with HFNC (very low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes chronic lung disease compared with HFNC (very low certainty).
1 finding from 1 review
Death or chronic lung disease · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Neurodevelopmental disability · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review